Information to authors
Legal regulation of plant genome editing using the example of CRISPR/Cas9 technology
SUMMARY. The authors discover legal approaches to regulating the gene editing technology, in particular CRISPR/Cas9 technology: the product-oriented and the process-oriented approaches. Relevant legislation of the United States and the EU as well as some international treaties have been analyzed. The authors consider the issue of regulation of gene editing within the scope of GMO legislation or general legislation on risk assessment and risk regulation. The issue of patenting the technology of gene editing in the legislation of the United States, the EU, as well as under international law has been considered. The authors describe «patent wars» between the scientific teams of developers of CRISPR/Cas9 technology. The question of the possibility of obtaining patent protection for plants derived by means of geno-me editing technologies has been investigated.
Key words: genome editing, CRISPR/Cas9 technology, legal regulation, EU legislation, US legislation, international law, patents
E-mail: medvedieva.maryna gmail.com, blume.yaroslav nas.gov.ua
|Coded & Designed by Volodymyr Duplij||Modified 25.07.21|